Show simple item record

AuthorYounes, Nadin
AuthorAl-Sadeq, Duaa W
AuthorAl-Jighefee, Hadeel
AuthorYounes, Salma
AuthorAl-Jamal, Ola
AuthorDaas, Hanin I
AuthorYassine, Hadi M
AuthorNasrallah, Gheyath K
Available date2020-05-31T05:51:54Z
Publication Date2020-05-01
Publication NameViruses
Identifierhttp://dx.doi.org/10.3390/v12060582
CitationYounes, N.; Al-Sadeq, D.W.; AL-Jighefee, H.; Younes, S.; Al-Jamal, O.; Daas, H.I.; Yassine, H.M.; Nasrallah, G.K. Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2. Viruses 2020, 12, 582
IdentifierArticle # 582
URIhttp://hdl.handle.net/10576/14981
AbstractThe recent outbreak of the Coronavirus disease 2019 (COVID-19) has quickly spread worldwide since its discovery in Wuhan city, China in December 2019. A comprehensive strategy, including surveillance, diagnostics, research, clinical treatment, and development of vaccines, is urgently needed to win the battle against COVID-19. The past three unprecedented outbreaks of emerging human coronavirus infections at the beginning of the 21st century have highlighted the importance of readily available, accurate, and rapid diagnostic technologies to contain emerging and re-emerging pandemics. Real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) based assays performed on respiratory specimens remain the gold standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging with high sensitivity and specificity as well. Even though excellent techniques are available for the diagnosis of symptomatic patients with COVID-19 in well-equipped laboratories; critical gaps still remain in screening asymptomatic people who are in the incubation phase of the virus, as well as in the accurate determination of live viral shedding during convalescence to inform decisions for ending isolation. This review article aims to discuss the currently available laboratory methods and surveillance technologies available for the detection of COVID-19, their performance characteristics and highlight the gaps in current diagnostic capacity, and finally, propose potential solutions. We also summarize the specifications of the majority of the available commercial kits (PCR, EIA, and POC) for laboratory diagnosis of COVID-19.
Languageen
PublisherMDPI
SubjectCOVID-19
SARS-CoV-2
diagnostic challenges
molecular testing
serology
viruses
TitleChallenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
TypeArticle
Issue Number6
Volume Number12
dc.accessType Open Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record